Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase-II Randomized Control Trial of Nasal Microbiota Transplant Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

NCT05400616 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT05400616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05400616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase-II Randomized Control Trial of Nasal Microbiota Transplant Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Lead sponsor
The University of Queensland
Phase
Not applicable
Overall status
Unknown status
Start date
November 10, 2022
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis (diagnosis)